Ligand Pharmaceuticals
LGND
LGND
180 hedge funds and large institutions have $1.15B invested in Ligand Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 65 increasing their positions, 63 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
180
Holders Change
+6
Holders Change %
+3.45%
% of All Funds
4.8%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
30
Increased
65
Reduced
63
Closed
23
Calls
$1.83M
Puts
$2.45M
Net Calls
-$629K
Net Calls Change
+$2.74M
Top Buyers
| 1 |
FMA
Fiduciary Management Associates
Chicago,
Illinois
|
+$15.6M |
| 2 |
KI
Kalmar Investments
Greenville,
Delaware
|
+$15.4M |
| 3 |
BC
Broadfin Capital
New York
|
+$10.6M |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$5.84M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$5.82M |
Top Sellers
| 1 |
GAM
Gotham Asset Management
New York
|
-$29.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$24.7M |
| 3 |
CM
Castleark Management
Chicago,
Illinois
|
-$15.9M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$13.2M |
| 5 |
TCP
TAMRO Capital Partners
Alexandria,
Virginia
|
-$7.18M |
